Artificial Intelligence Enhances Diagnosis and Management of Atopic Dermatitis: A New Report
Click to start listening
New Delhi, Dec 26 (NationPress) Artificial Intelligence (AI) emerges as a powerful asset in the identification and treatment of atopic dermatitis, a long-term skin disorder, facilitating earlier, more accurate, and standardized recognition of the condition, thereby enhancing patient results, as indicated in a report released on Thursday.
Atopic dermatitis is a multifaceted condition that presents a variety of clinical symptoms. In its more severe forms, this skin disorder can lead to sleep disruptions caused by the itchy rashes that occur during flare-ups, along with issues like depression, anxiety, and reduced productivity.
Over the years, effectively managing atopic dermatitis has been a primary concern for healthcare providers, as the quality of life for these patients is significantly impacted by the bothersome symptoms they face, which include itchiness and skin inflammation.
Diagnosis for atopic dermatitis is largely clinical and may carry a subjective bias, leading to inconsistencies in how it is diagnosed. In the age of AI, various trends have emerged that leverage AI across different fields, making a substantial difference, particularly in healthcare.
The report by GlobalData, a data analytics firm, points out that the absence of objective biomarkers for a definitive diagnosis and severity assessment of chronic skin disorders complicates the diagnostic process.
“AI presents innovative solutions to healthcare challenges by mimicking human intelligence in machines, with advancements that are set to revolutionize diagnostics, drug discovery, and personalized medicine,” stated Filippos Maniatis, Healthcare Analyst at GlobalData.
“With AI-driven image recognition, it is possible to identify distinct severity patterns in skin lesion images, and through machine learning,” Maniatis added, emphasizing that “the accuracy of diagnosis regarding severity can be significantly enhanced over time.”
Research has shown that AI can facilitate more customized treatment schemes, continuous monitoring, and the utilization of technological advancements. For instance, wearable devices integrated with AI can provide constant monitoring of skin conditions, offering real-time data essential for managing the disease.
Wearable technology that incorporates AI supports ongoing observation, which can help physicians make timely adjustments to treatment plans based on changes in disease severity (such as flare-ups). This has garnered the interest of several technology firms, according to the report.
“These technologies showcase their potential to enhance existing diagnostic and management approaches for the condition. Collaborative efforts among AI experts, clinicians, and researchers are crucial to fully grasp AI’s capabilities in refining the management of atopic dermatitis,” said Maniatis.
